A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2004
12/01/2004	CN1551766A Lymphocytic activation inhibitor and remedial agent for autoimmune disease
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1550233A Skin patch and method for administering testosterone
12/01/2004	CN1177865C Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
12/01/2004	CN1177860C Cholenic acid amides and pharmaceutical compositions thereof
12/01/2004	CN1177857C Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
12/01/2004	CN1177852C Phosphonic diester derivatives
12/01/2004	CN1177844C Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177825C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
12/01/2004	CN1177808C Solid compositions suitable for oral administration composing L-carnitine and alkanoyl-L-carnitine mangesium tartrate
12/01/2004	CN1177595C Use of composition for increasing insulin activity
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825360 Bicyclic aromatic compounds
11/30/2004	US6825349 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders
11/30/2004	US6825321 For breeding cold-avoidance plants; treatment of diabetes metllitus/obesity; development of thermogenic bio-materials
11/30/2004	US6825318 Vaccine for obesity therapy; hybrid polypeptides
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6825229 Administering protein kinase c activators such as macrocyclic lactones (i.e. bryostatin class and neristatin class)
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825223 Anilide compounds and pharmaceutical compositions comprising them
11/30/2004	US6825222 Modulators of peroxisome proliferator activated receptors
11/30/2004	US6825221 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
11/30/2004	US6825220 3-Substituted oxindole β 3 agonists
11/30/2004	US6825219 Substituted benzimidazole compounds
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825213 β3-adrenoreceptor agonists, agonist compositions and methods of using
11/30/2004	US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004	US6825202 Central nervous system disorders; psychological disorders
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825193 Heterocyclic amines such as 4-(3,4-dichlorophenyl)-2-(2-(4-methylpiperazin-1-yl)-benzylidene) -thiomorpholin-3-one, used as antiserotonine agents
11/30/2004	US6825190 Protein kinase inhibitors and uses thereof
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6825179 Active ingredient combinations or adducts of cyclodextrins and quinones
11/30/2004	US6825173 Preparation of fagopyritols and uses therefor
11/30/2004	US6825015 Process for the obtaining of HMG-COA reductase inhibitors of high purity
11/30/2004	US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids
11/30/2004	US6824811 Concentrate of triterpenes
11/30/2004	US6824789 Method of extracting antioxidants from lamiaceae species and the extract products thereof
11/30/2004	CA2298245C Matrix controlled release device
11/25/2004	WO2004101752A2 Compounds for treatment of inflammation, diabetes and related disorders
11/25/2004	WO2004101619A1 Rational design and synthesis of functional glycopeptide
11/25/2004	WO2004101593A1 5'-modified nucleoside derivative and medicinal use thereof
11/25/2004	WO2004101561A1 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
11/25/2004	WO2004101529A1 Nitrogenous heterocyclic compound and medical use thereof
11/25/2004	WO2004101528A2 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	WO2004101526A1 Polymorphous crystal of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-qunolinecarboxamide and method for preparation thereof
11/25/2004	WO2004101514A1 Cyanofluoropyrrolidine derivative
11/25/2004	WO2004101505A1 Novel compounds for treatment of obesity
11/25/2004	WO2004101493A1 Acid addition salt of carbasugar amine derivative
11/25/2004	WO2004101483A1 Novel trisubstituted benzene derivative, process for producing the same and medical drug composition containing the derivative
11/25/2004	WO2004100976A1 Klotho protein, anti-klotho protein antibody and use thereof
11/25/2004	WO2004100972A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	WO2004100969A1 Remedy
11/25/2004	WO2004100959A1 External patch containing estrogen and/or progestogen
11/25/2004	WO2004100951A1 Diabetic neuropathy diagnostic and therapeutic
11/25/2004	WO2004100945A1 Use of phthalide derivatives for the treatment and prevention of diabetes mellitus
11/25/2004	WO2004100942A1 Composition for lowering lipid in body
11/25/2004	WO2004100936A1 Therapeutic agent
11/25/2004	WO2004100924A2 Method of preparing a formulation containing a microdosed active principle
11/25/2004	WO2004087173A3 Formulations for mediating inflammation and for reducing blood cholesterol
11/25/2004	WO2004073611A3 Compounds for the treatment of metabolic disorders
11/25/2004	WO2004071416B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/25/2004	WO2004067489A3 Hydroxyl compounds and compositions for cholesterol management and related uses
11/25/2004	WO2004062606A3 Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
11/25/2004	WO2004021984A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues
11/25/2004	WO2003101945A8 Ligands that are inhibitors of the rar receptors
11/25/2004	WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004	US20040236147 Integrin antagonist; antiinflammatory agents; antiarthritic agents; inflammatory bowel disease; lupus; multiple sclerosis; asthma; psoriasis;antidiabetic agents; cardiovascular disorders
11/25/2004	US20040236135 Preparation and use of alpha-keto phosphonates
11/25/2004	US20040236111 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/25/2004	US20040236108 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO); treat an inflammatory disease or condition, related to carbohydrate metabolism, smooth muscle cell function; chemical synthesis
11/25/2004	US20040236104 Substituted 4-aminocyclohexanols
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004	US20040236098 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040235945 Combining EDTA-sodium-metal complex(es) and the sodium selenite solution to from trace element soultuton to provide the solution to the animals
11/25/2004	US20040235933 Administering aromatic or heteroaromatic substituted indolealkanoic acid derivataives for the treatment of chronic complications arising from diabetes mellitus e.g. diabetic cataracts, retinopathy, nephropathy and neuropathy
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235924 antidepressants; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches;drug addition; antiinflammatory agents
11/25/2004	US20040235923 mixture of threonine, proline, glycine, valine, isoleucine, leucine, tyrosine, phenylalanine, lysine, aspartic acid, serine, glutamic acid, alanine, methionine, histidine and arginine as a unit; reduction of accumulated body fat, alleviation of excess sensitivity to cold, warming of a cold body
11/25/2004	US20040235921 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist
11/25/2004	US20040235912 preventing, treating diabetes mellitus, Syndrome X, cardiovascular disease , hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis in a mammal
11/25/2004	US20040235906 Substituted amine derivatives and their use as monoamine neurotransmitter re-up-take inhibitors
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235866 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235858 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
11/25/2004	US20040235854 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents

1 ... 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 ... 1298